James Driscoll, MD, PhD
The Driscoll Lab focuses its research on increased understanding of the biology of plasma cells under physiologic and pathologic conditions as a means to improve human health. Over the past decade, they focused their laboratory and clinical research studies on the plasma cell malignancy multiple myeloma (MM).
- Ear, Nose & Throat
Martin L. Basch, PhD
The Basch Lab uses mouse embryo as a model system to understand how the inner ear forms. The lab studies how the different cell types in the cochlea interact with each other during embryonic development. The lab goal is to apply the lessons learned from normal development towards regenerative therapies in cases of congenital deafness and age-related hearing loss.
- Harrington Discovery Institute
Atul Chopra, MD PhD
The Chopra lab focuses its research in the field of energy homeostasis and metabolic disease. Through the assessment of humans with genetic defects in the processing of energy, the lab works to identify new genes and pathways that have escaped attention so far. Its goal is to identify novel processes and paradigms within the realm of energy homeostasis using human and mouse genetics as well as cutting edge molecular biology.
Seth Field, MD
The goal of the Field lab is to use discoveries in fundamental biology to fuel the development of new approaches to treat human disease and provide insight into the mysterious organelle, the Golgi.
Mukesh K. Jain, MD
The Jain laboratory identified KLFs as nodal regulators of cardiovascular biology and metabolism. Mukesh K. Jain, MD translated this work and established KLFs as key targets of pharmacologic agents.
Andrew Pieper, MD
The Pieper lab strives to identify and pursue important biological insights into neuropsychiatry, with particular focus on neurodegeneration in disease, injury, and normal aging. The ultimate goal is to improve human brain health through translational basic science leading to new therapies for patients suffering from currently incurable or difficult to treat neuropsychiatric disorders.
Jonathan Stamler, MD
The Stamler lab pioneered the field of S-nitrosylation-mediated protein control, a fundamental mechanism of cellular regulation and signaling that operates across phylogeny and cell type. It is currently developing first in-class agents that modulate S-nitrosylation in a tissue and target-specific manner, promising new treatments for human disease.
Irina Pikuleva, PhD
Vice Chair of Research
Carl F. Asseff, M.D. Professor of Ophthalmology
Director of the Visual Sciences Research Center
Case Western Reserve University
Robert Salomon, PhD (secondary appointment)
Mabery Professor of Chemistry and Ophthalmology, Case Western Reserve University